• Plk1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-06-18

  This study elucidates how Polo-like kinase 1 (Plk1) phosphorylates p31comet, suppressing its ability to disassemble mitotic checkpoint complexes (MCC) and thereby refining the timing of anaphase onset. These mechanistic insights advance our understanding of mitotic progression and have direct implications for research targeting chromosome segregation and spindle assembly checkpoint fidelity.

• 5X Protein Loading Buffer (Reducing): Technical SDS-PAGE Use

  2026-06-17

  5X Protein Loading Buffer (Reducing) is formulated for protein sample preparation in SDS-PAGE workflows requiring thorough denaturation and disulfide bond reduction. It ensures accurate protein molecular weight separation and should not be used for non-reducing or native protein analyses.

• Nuclear cGAS-TRIM41 Pathway Suppresses L1 Retrotransposition

  2026-06-17

  This study uncovers a nuclear role for cGAS in repressing LINE-1 (L1) retrotransposition through CHK2-dependent phosphorylation and TRIM41-mediated ORF2p degradation. The findings provide new mechanistic insight into genome stability maintenance, with implications for aging and cancer research.

• ACSL4 Drives Endometrial Decidualization via Fatty Acid β-Ox

  2026-06-16

  This study uncovers a pivotal role for long-chain acyl-CoA synthetase-4 (ACSL4) in promoting endometrial decidualization, not by lipid droplet accumulation, but through activation of the fatty acid β-oxidation pathway. These findings offer mechanistic clarity for reproductive biology and suggest new directions for hormone replacement therapy and endometriosis research.

• Perospirone (SM-9018): New Frontiers in Translational Resear

  2026-06-16

  Perospirone (SM-9018 freebase) is redefining the landscape of translational neuropsychiatric and cardiovascular research. This article explores its dual role as a potent serotonin–dopamine modulator and as an unexpected inhibitor of vascular Kv1.5 channels, integrating recent mechanistic insights and practical guidance for advancing experimental models. With a focus on APExBIO’s rigor and product reliability, the discussion positions Perospirone as an essential tool for researchers seeking both mechanistic depth and translational relevance.

• ML-Guided LNPs for Targeted mRNA Delivery to Hyperactive Mic

  2026-06-15

  Rafiei et al. present a machine learning-driven platform to design immunomodulatory lipid nanoparticles (LNPs) that efficiently deliver mRNA to hyperactivated microglia, achieving phenotype repolarization and inflammation control. This approach offers a robust strategy for neuroinflammatory disorder therapies and advances the rational engineering of mRNA delivery vehicles.

• Allosteric Aptamer Biosensor Enables Live Tracking of Native

  2026-06-15

  A newly developed allosteric genetically encoded biosensor—circStep—enables direct, real-time visualization of endogenous protein dynamics in living cells, overcoming limitations of conventional overexpression and genetic tagging. This platform offers high specificity and temporal resolution for studying native protein function and supports high-throughput drug screening applications.

• SNS-032 (BMS-387032): Multifunctional CDK Inhibitor in Oncol

  2026-06-14

  Explore the scientific depth of SNS-032 (BMS-387032), a potent CDK inhibitor, in cancer and advanced host-pathogen research. This article uniquely examines mechanistic and translational insights, bridging oncology with antiviral strategies.

• HyperScript™ Reverse Transcriptase: Precision cDNA Synthesis

  2026-06-13

  Unlock robust cDNA synthesis even from challenging, structured, or low-abundance RNA using HyperScript™ Reverse Transcriptase. Its engineered thermal stability and reduced RNase H activity streamline advanced qPCR workflows, providing unmatched sensitivity and fidelity where conventional enzymes falter.

• Thiamet G: Advanced O-GlcNAcase Inhibitor Workflows & Soluti

  2026-06-12

  Thiamet G empowers researchers to precisely elevate O-GlcNAcylation, unlocking new avenues in neurodegenerative and metabolic disease models. This guide translates the latest breakthroughs into actionable protocols and troubleshooting tips for reliable, reproducible results.

• Alternariol (AOH): Mechanistic Insights and Translational St

  2026-06-12

  This thought-leadership article explores how Alternariol (AOH), a potent mycotoxin produced by Alternaria species, disrupts cellular and hepatic pathways—driving fibrosis, apoptosis, and toxicity. Combining mechanistic omics findings, protocol optimization, and strategic guidance, it positions APExBIO's AOH as a critical asset for translational researchers advancing mycotoxin and liver disease research.

• Direct Mouse Genotyping Kit Plus: Reliable Genomic DNA Extra

  2026-06-11

  This evidence-based article explores how the Direct Mouse Genotyping Kit Plus (SKU K1027) overcomes persistent laboratory challenges in mouse genotyping, with a focus on reproducibility and workflow efficiency. Drawing on recent lineage-tracing studies and best practices, it provides actionable guidance for researchers conducting transgene detection, gene knockout validation, and animal colony genetic screening.

• Azithromycin and Roxithromycin: Novel Senolytics Targeting S

  2026-06-11

  Ozsvari et al. (2018) identify azithromycin and roxithromycin as the first FDA-approved antibiotics with potent senolytic activity, selectively eliminating senescent human fibroblasts. Their study pioneers a streamlined drug screening protocol and provides mechanistic insight, highlighting new opportunities for translational research in cellular aging.

• Dutasteride (SKU A1659): Precision Tools for Prostate Cancer

  2026-06-10

  This article delivers scenario-driven, evidence-based guidance for researchers leveraging Dutasteride (SKU A1659) in cell viability, proliferation, and cytotoxicity assays. It addresses common workflow challenges, interprets quantitative data, and demonstrates how APExBIO’s Dutasteride advances reproducibility and experimental rigor.

• Obeticholic Acid in Advanced Liver Fibrosis: Mechanistic Bri

  2026-06-10

  Explore how Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid) is redefining liver fibrosis research through FXR signaling and unique cross-talk with immunometabolic pathways. This article delivers a nuanced, scientifically rigorous analysis distinct from existing content.

448 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page